Skip to main content
. 2023;24(1):195–205. doi: 10.31557/APJCP.2023.24.1.195

Table 1.

Relation of ERCC1 Expression with Demographic Characteristics of the Studied Group

ERCC1 Expression
Low High p-value
Age (years) ≤ 55 27 (54.0%) 23 (46.0%) 0.974
> 55 22 (53.7%) 19 (46.3%)
Sex Male 25 (49.0%) 26 (51.0%) 0.297
Female 24 (60.0%) 16 (40.0%)
Residence Shobra 13 (61.9%) 8 (38.1%) 0.556
Helwan 10 (45.5%) 12 (54.5%)
Others 26 (54.2%) 22 (45.8%)
Smoking Non- or Ex-smoker 30 (58.8%) 21 (41.2%) 0.282
Current Smoker 19 (47.5%) 21 (52.5%)
Pathology Epithelioid 44 (57.1%) 33 (42.9%) 0.139
Sarcomatoid/biphasic 5 (35.7%) 9 (64.3%)
Treatment Protocol GEM 20 (55.6%) 16 (44.4%) 0.791
Alimta 29 (52.7%) 26 (47.3%)
Response Regressive 24 (68.6%) 11 (31.4%) 0.019
Progressive 13 (36.1%) 23 (63.9%)
Stable 12 (60.0%) 8 (40.0%)